| Customization: | Available |
|---|---|
| CAS No.: | 121062-08-6 |
| Formula: | C50h69n15o9 |
|
Still deciding? Get samples of US$ 240/G
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product Name | Dihexa |
| CAS NO. | N/A |
| Other name | N/A |
| Appearance | White powder |
| Purity | 98% HPLC |
| Application | Research peptides |
| Shelf Life | 24 Months |
| Storage | Store at a temperature of 2-8 degrees, protected from light. |
Dihexa (developmental code PNB-0408; also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide)
Evidence Summary
Dihexa improves cognition and increases synapses in rat models of cognitive dysfunction, but no studies have evaluated its long-term safety, including potential tumorigenenic and cancer metastatic effects.
Neuroprotective Benefit: In rat models of cognitive dysfunction, dihexa treatment improves cognition and increases spines/synapses. Dihexa did not improve cognitive functions in rats with normal cognition. No studies in humans have been published to date.
Aging and related health concerns: No studies have examined dihexa for age-related diseases. Theoretically, dihexa via activation of HGF and c-Met could promote tumorigenesis and cancer progression.
Safety: No studies in animals or humans have examined the long-term safety of dihexa. Dihexa has a long half-life and there are theoretical concerns of c-Met activation leading to tumorigenesis and cancer progression.
){kind=link}